Cornelis J H van de Velde Selected Research

Carcinoma (Carcinomatosis)

10/2015	Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
6/2015	uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery.
3/2014	Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
7/2012	Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands.
12/2011	PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis.
8/2009	Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment.
5/2008	Clinical impact of HLA class I expression in rectal cancer.
5/2007	Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.
1/2006	Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components.
2/2004	EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cornelis J H van de Velde Research Topics

Disease

131	Neoplasms (Cancer) 01/2023 - 01/2002
77	Breast Neoplasms (Breast Cancer) 02/2024 - 04/2002
73	Rectal Neoplasms (Rectal Cancer) 04/2024 - 03/2002
41	Colorectal Neoplasms (Colorectal Cancer) 06/2019 - 05/2002
36	Stomach Neoplasms (Stomach Cancer) 06/2022 - 08/2002
35	Neoplasm Metastasis (Metastasis) 04/2024 - 07/2002
17	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2004
13	Carcinoma (Carcinomatosis) 10/2015 - 03/2002
9	Adenocarcinoma 01/2021 - 08/2002
8	Margins of Excision 04/2024 - 05/2007
4	Uveal melanoma 12/2016 - 02/2004
3	Infections 04/2024 - 12/2003
3	Neoplasm Micrometastasis 11/2016 - 12/2005
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016 - 11/2011
3	Lymphatic Metastasis 05/2011 - 12/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016 - 01/2013
2	Adenoma (Adenomas) 09/2016 - 11/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 01/2015
2	Parathyroid Neoplasms (Parathyroid Neoplasm) 11/2015 - 06/2014
2	Vulvar Neoplasms (Vulvar Cancer) 12/2014 - 01/2012
2	Carcinogenesis 07/2014 - 06/2002

Drug/Important Bio-Agent (IBA)

30	Hormones (Hormone)IBA 02/2024 - 01/2007
22	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2007
20	Tamoxifen FDA LinkGeneric 01/2023 - 01/2009
20	exemestane (Aromasin)FDA Link 01/2023 - 01/2011
15	ParaffinIBA 01/2021 - 08/2002
15	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2002
13	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020 - 05/2011
11	Proteins (Proteins, Gene)FDA Link 03/2019 - 01/2002
10	Formaldehyde (Formol)FDA Link 01/2021 - 05/2005
8	Estrogen ReceptorsIBA 01/2022 - 01/2007
8	Melphalan (Alkeran)FDA LinkGeneric 12/2016 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 05/2010
6	Capecitabine (Xeloda)FDA Link 01/2020 - 05/2010
6	Monoclonal AntibodiesIBA 11/2019 - 05/2004
6	Peptides (Polypeptides)IBA 03/2017 - 01/2004
6	HLA Antigens (Human Leukocyte Antigens)IBA 09/2016 - 10/2006
6	EnzymesIBA 11/2014 - 07/2002
5	RNA (Ribonucleic Acid)IBA 01/2022 - 08/2002
5	HLA-G Antigens (HLA G)IBA 01/2018 - 12/2010
5	VaccinesIBA 04/2013 - 05/2002
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2022 - 05/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 02/2007
4	Letrozole (Femara)FDA LinkGeneric 01/2021 - 01/2018
4	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 05/2009
4	AntibodiesIBA 11/2019 - 12/2008
4	Carcinoembryonic AntigenIBA 10/2018 - 10/2015
4	Aromatase InhibitorsIBA 01/2018 - 01/2011
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 12/2012
4	Contrast MediaIBA 09/2016 - 07/2010
4	Methylene Blue (Methylthioninium Chloride)FDA Link 11/2015 - 07/2012
4	Histones (Histone)IBA 05/2015 - 01/2014
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2014 - 05/2007
4	Human Serum Albumin FDA LinkGeneric 01/2013 - 11/2011
3	Trinitrotoluene (TNT)IBA 04/2024 - 01/2022
3	Estrogens (Estrogen)FDA Link 01/2021 - 04/2016
3	Epithelial Cell Adhesion MoleculeIBA 03/2019 - 02/2007
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2007
3	IntegrinsIBA 03/2017 - 12/2014
3	Urokinase Plasminogen Activator ReceptorsIBA 12/2016 - 01/2011
3	EpitopesIBA 09/2016 - 04/2004
3	Folate Receptor 1IBA 05/2016 - 01/2016
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2015 - 01/2011
3	AntigensIBA 05/2014 - 05/2002
3	HLA-A Antigens (HLA-A)IBA 10/2006 - 01/2004
2	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 02/2024 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 01/2021 - 09/2005
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 09/2005
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2019
2	Immunoglobulin FragmentsIBA 03/2019 - 10/2015
2	ElementsIBA 12/2018 - 08/2012
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 10/2008
2	LigandsIBA 01/2016 - 01/2012
2	Sirtuin 1IBA 01/2015 - 08/2014
2	Coloring Agents (Dyes)IBA 12/2014 - 07/2013
2	Phenobarbital (Luminal)FDA Link 07/2014 - 06/2011
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2014 - 05/2007
2	Keratins (Keratin)IBA 09/2013 - 05/2011
2	AlbuminsIBA 05/2013 - 05/2011
2	InterferonsIBA 04/2013 - 09/2007

Therapy/Procedure

63	Radiotherapy 04/2024 - 03/2002
60	Therapeutics 02/2024 - 03/2002
39	Drug Therapy (Chemotherapy) 04/2024 - 04/2002
22	Neoadjuvant Therapy 04/2024 - 06/2009
21	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 03/2004
19	Adjuvant Chemotherapy 01/2021 - 01/2007
17	Chemoradiotherapy 04/2024 - 05/2010
7	Gastrectomy 12/2019 - 12/2005
6	Immunotherapy 06/2019 - 01/2004
5	Segmental Mastectomy (Lumpectomy) 01/2018 - 08/2011
4	Computer-Assisted Surgery (Image Guided Surgery) 11/2019 - 04/2011
4	Aftercare (After-Treatment) 01/2016 - 02/2004
4	Proctectomy 06/2013 - 07/2007
3	Lasers (Laser) 01/2015 - 10/2005
2	Induction Chemotherapy 12/2019 - 12/2018
2	Operative Surgical Procedures 01/2018 - 05/2009
2	Mastectomy (Mammectomy) 01/2018 - 01/2018
2	Cytoreduction Surgical Procedures 01/2016 - 01/2015
2	Intravenous Administration 01/2015 - 07/2003
2	Adjuvant Chemoradiotherapy 01/2012 - 12/2005